- Home
- CTSH vs ALC Comparison
CTSH vs ALC Comparison
Compare CTSH & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSH
- ALC
- Stock Information
- Founded
- CTSH 1994
- ALC 1945
- Country
- CTSH United States
- ALC Switzerland
- Employees
- CTSH N/A
- ALC N/A
- Industry
- CTSH EDP Services
- ALC Ophthalmic Goods
- Sector
- CTSH Technology
- ALC Health Care
- Exchange
- CTSH Nasdaq
- ALC Nasdaq
- Market Cap
- CTSH 38.7B
- ALC 44.0B
- IPO Year
- CTSH 1998
- ALC N/A
- Fundamental
- Price
- CTSH $75.90
- ALC $95.78
- Analyst Decision
- CTSH Hold
- ALC Buy
- Analyst Count
- CTSH 17
- ALC 12
- Target Price
- CTSH $84.56
- ALC $104.90
- AVG Volume (30 Days)
- CTSH 4.4M
- ALC 1.4M
- Earning Date
- CTSH 04-30-2025
- ALC 05-12-2025
- Dividend Yield
- CTSH 1.64%
- ALC 0.28%
- EPS Growth
- CTSH 7.13
- ALC 4.59
- EPS
- CTSH 4.51
- ALC 2.05
- Revenue
- CTSH $19,736,000,000.00
- ALC $9,911,000,000.00
- Revenue This Year
- CTSH $6.97
- ALC $6.19
- Revenue Next Year
- CTSH $5.38
- ALC $7.00
- P/E Ratio
- CTSH $17.20
- ALC $46.54
- Revenue Growth
- CTSH 1.98
- ALC 4.82
- 52 Week Low
- CTSH $63.79
- ALC $77.54
- 52 Week High
- CTSH $90.82
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- CTSH 32.51
- ALC 61.36
- Support Level
- CTSH $75.50
- ALC $90.64
- Resistance Level
- CTSH $80.52
- ALC $97.40
- Average True Range (ATR)
- CTSH 1.70
- ALC 1.31
- MACD
- CTSH -0.32
- ALC 0.53
- Stochastic Oscillator
- CTSH 4.83
- ALC 84.79
About CTSH Cognizant Technology Solutions Corporation
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 350,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the U.S. contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.